Biological sampling is named as an intervention in 2 current clinical trials in our France and Netherlands registers. 1 is recruiting patients now. All registered phases are Not applicable. The sponsor with the most trials is University Hospital, Bordeaux (1). The most-studied condition is Myelodysplastic Syndromes.
| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
NCT05924074 · ClinicalTrials.gov ↗ · Myelodysplastic Syndromes, Ferroptosis
|
Not applicable | Recruiting | University Hospital, Bordeaux | France |
|
NutrImmune: Precision Nutrition to Improve Immunity in Individuals With Obesity
NCT07850206 · ClinicalTrials.gov ↗ · Obesity (BMI>30), Immune Abnormalities, Low-grade Inflammation
|
Not applicable | Not yet open | Institut National de la Santé Et de la Recherche Médicale, France | Netherlands |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Lead sponsor | Trials |
|---|---|
| University Hospital, Bordeaux | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in France | 1 | 1 |
| Clinical trials in Netherlands | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
2 current trials in our France and Netherlands registers name Biological sampling as a drug or biological intervention, as of the registry sync on 1 October 2026. Completed and withdrawn studies are not counted.
Yes. 1 of the 2 trials is recruiting: 1 with sites in France. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
University Hospital, Bordeaux (1) and Institut National de la Santé Et de la Recherche Médicale, France (1). The number in brackets is how many trials each organisation leads.
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Biological sampling works or whether it is effective, and it is not medical advice.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Biological sampling works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Biological sampling (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 1 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.